Day: January 24, 2023
FDA proposes new lead limits for baby food to reduce potential risks to children’s health
Jgi/jamie Grill | Tetra Images | Getty Images The Food and Drug Administration proposed new limits Tuesday on lead in baby food, in an effort to reduce exposure to a toxin that can impair childhood development. The lead limits apply to processed food consumed by children younger than two years old. In a statement, FDA […]
Read More
Danaher’s stock drop looks like a buying opportunity after it reported a solid quarter
Life sciences and medical diagnostics company Danaher (DHR) reported better-than-expected earnings and revenue for the fourth quarter. We view the dip in the stock as unjustified and an opportunity. Revenue increased nearly 10% on a core basis to $8.37 billion, well above estimates of $7.9 billion, according to Refinitiv. Adjusted profit increased 6.7% to $2.87 […]
Read More
Amazon adds generic prescription perk for Prime members
Amazon on Tuesday announced a new prescription perk for U.S. Prime members, hoping to boost subscriptions and attract users to its pharmacy service. The add-on, called RxPass, will allow Prime members to get as many drugs as they need from a list of 50 generic medications to treat more than 80 common chronic conditions, such […]
Read More
Jim Cramer’s Investing Club meeting Tuesday: J&J, Danaher, AMD
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Buy JNJ while it’s down Look to buy Danaher Wait to buy AMD 1. Buy JNJ while it’s down Shares of Johnson & Johnson (JNJ) slipped more than 1% Tuesday […]
Read More
The FDA’s power to approve drugs faces sweeping challenge in lawsuit seeking to pull abortion pill from U.S. market
Mifepristone (Mifeprex) and Misoprostol, the two drugs used in a medication abortion, are seen at the Women’s Reproductive Clinic, which provides legal medication abortion services, in Santa Teresa, New Mexico, on June 17, 2022. Robyn Beck | AFP | Getty Images The Food and Drug Administration is squaring off with anti-abortion physicians in an unprecedented […]
Read More